Leaderboards/Migraine and Headache Studies

Migraine and Headache Studies

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Edoardo Caronna
Universitat Autònoma de Barcelona
2
Alicia Alpuente
Universitat Autònoma de Barcelona
3
Marcello Silvestro
University of Naples Federico II
4
Nazia Karsan
King's College London
5
Mohammad Al‐Mahdi Al‐Karagholi
Copenhagen University Hospital
6
Lucas Hendrik Overeem
Humboldt-Universität zu Berlin
7
Simone de Vries Lentsch
Leiden University Medical Center
8
Lite Yang
Brigham and Women's Hospital
9
Marta Torres‐Ferrús
Universitat Autònoma de Barcelona
10
Haidar M. Al‐Khazali
Copenhagen University Hospital

Rising Stars Papers

1
CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
Handbook of clinical neurology|2024
37 cit.
2
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of Neurology Neurosurgery & Psychiatry|2024
36 cit.
3
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies
Cephalalgia|2024
23 cit.
4
PACAP38-induced migraine attacks are independent of CGRP signaling: a randomized controlled trial
The Journal of Headache and Pain|2025
20 cit.
5
Pathophysiology of Migraine
CONTINUUM Lifelong Learning in Neurology|2024
12 cit.
6
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization
The Journal of Headache and Pain|2024
12 cit.
7
Consistency between headache diagnoses and ICHD-3 criteria across different levels of care
The Journal of Headache and Pain|2025
11 cit.
8
The state of art on the use of patient reported outcomes in migraine
Current Opinion in Neurology|2024
9 cit.
9
Hypersensitivity to BKCa channel opening in persistent post-traumatic headache
The Journal of Headache and Pain|2024
8 cit.
10
Effects of substance P on headache induction and arterial dilation in healthy adults
Cephalalgia|2025
8 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Jyun Yan Yang
Eli Lilly (United States)
2
Mads Barloese
University of Copenhagen
3
Aubrey Manack Adams
AbbVie (United States)
4
Christopher S. Walker
University of Auckland
5
Pooja Desai
Amgen (United States)
6
Pamela Vo
EVERSANA (Canada)
7
Kaname Ueda
Eli Lilly (Japan)
8
Lidiane Lima Florêncio
Universidad Rey Juan Carlos
9
Michael Eller
Innsbruck Medical University
10
Tina M. Oakes
Eli Lilly (United States)

Emerging Leaders Papers

1
Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
Frontiers in Neurology|2022
59 cit.
2
The economic and personal burden of cluster headache: a controlled cross-sectional study
The Journal of Headache and Pain|2022
33 cit.
3
CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons
Frontiers in Physiology|2022
28 cit.
4
The cervical spine in tension type headache
Musculoskeletal Science and Practice|2023
25 cit.
5
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care
Cephalalgia|2023
21 cit.
6
Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
The Journal of Headache and Pain|2023
18 cit.
7
Transition of cluster headache phenotype: An interview-based study
Cephalalgia|2023
16 cit.
8
Immediate Effects of Dry Needing or Manual Pressure Release of Upper Trapezius Trigger Points on Muscle Activity During the Craniocervical Flexion Test in People with Chronic Neck Pain: A Randomized Clinical Trial
Pain Medicine|2022
15 cit.
9
Neck pain repercussions in migraine – The role of physiotherapy
Musculoskeletal Science and Practice|2023
14 cit.
10
Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE
Neurology and Therapy|2023
12 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Peter J. Goadsby
King's College London
2
Jes Olesen
Glostrup Hospital
3
Richard B. Lipton
Albert Einstein College of Medicine
4
Messoud Ashina
University of Copenhagen
5
Rami Burstein
Beth Israel Deaconess Medical Center
6
Lars Edvinsson
Lund University
7
Michael A. Moskowitz
Harvard University
8
Michel D. Ferrari
Leiden University
9
Rigmor Jensen
Rigshospitalet
10
Walter F. Stewart
Center for Advancing Health

Current Senior Leaders Papers

1
The International Classification of Headache Disorders: 2nd edition
The Lancet Neurology|2003
5.1k cit.
2
A Report on the Journal 2004
Cephalalgia|2004
2.4k cit.
3
Migraine prevalence, disease burden, and the need for preventive therapy
Neurology|2007
2.3k cit.
4
The International Classification of Headache Disorders
Headache The Journal of Head and Face Pain|2008
2.3k cit.
5
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Headache The Journal of Head and Face Pain|2001
2.3k cit.
6
Prevalence and burden of overactive bladder in the United States
World Journal of Urology|2003
2.3k cit.
7
Preface to the Second Edition
Cephalalgia|2004
2.1k cit.
8
Cost of disorders of the brain in Europe 2010
European Neuropsychopharmacology|2011
1.7k cit.
9
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
Annals of Neurology|1990
1.6k cit.
10
Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce
JAMA|2003
1.6k cit.

Reagents for Migraine and Headache Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

FABP3 (A7) Mouse Monoclonal Antibody

#14780$158,348
View Evidence →
Cell Signaling TechnologyEvidence 65

Synaptophysin (7H12) Mouse Monoclonal Antibody (BSA and Azide Free)

#36451$865
View Evidence →
PromegaEvidence 72

qPCR Kits: GoTaq® qPCR and RT-qPCR Systems

#A6002
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 68

DKK1 Antibody

Cited in 5 papers
#4687$317
View Evidence →
Cell Signaling TechnologyEvidence 63

AFP (F2E9D) Rabbit Monoclonal Antibody

#35190$178,415
View Evidence →
Cell Signaling TechnologyEvidence 65

S6 Ribosomal Protein (5G10) Rabbit Monoclonal Antibody (Biotinylated)

#14798$556
View Evidence →